A multicenter randomized trial in The Lancet Regional Health – Western Pacific found that sitafloxacin monotherapy is non-inferior to standard doxycycline–rifampicin combination therapy for acute uncomplicated brucellosis, with a superior safety and tolerability profile. This finding may simplify treatment and improve patient adherence in endemic regions. — Photo by Thirdman on Pexels (Pexels License)
MD, MPH, PhD. Editor-in-Chief, Georgian Medical Journal (GMJ). Professor and Head, School of Public Health, David Tvildiani Medical University (DTMU), Tbilisi, Georgia. Chair, Public Health Institute of Georgia (PHIG). President, Accréditation Sans Frontières (ASF), Paris. Secretary/Treasurer, UEMS Section of Public Health. WHO Consultant, Health and Migration, Geneva. Former Member, UN Secretary-General's Independent Accountability Panel for Every Woman, Every Child, Every Adolescent (IAP-EWEC, 2016–2021). ORCID: 0000-0001-7609-4515.
